Loading…
Silo Pharma, Inc. is projected to rise to $9.01 by 2027, a +17% move from its current price of $7.73. SILO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $7.13 | $7.73 | $8.38 | +0.01% |
| Jul 14 | $6.90 | $7.73 | $8.66 | +0.01% |
| Jul 15 | $6.72 | $7.73 | $8.89 | +0.02% |
| Jul 16 | $6.58 | $7.73 | $9.08 | +0.02% |
| Jul 17 | $6.46 | $7.73 | $9.26 | +0.03% |
| Jul 18 | $6.35 | $7.73 | $9.42 | +0.04% |
| Jul 19 | $6.25 | $7.73 | $9.57 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.25 | $7.73 | $9.57 | +0.04% |
| Week 2 | $5.72 | $7.74 | $10.46 | +0.08% |
| Week 3 | $5.35 | $7.74 | $11.20 | +0.12% |
| Week 4 | $5.06 | $7.74 | $11.86 | +0.17% |
| Week 5 | $4.81 | $7.75 | $12.47 | +0.21% |
| Week 6 | $4.60 | $7.75 | $13.06 | +0.25% |
| Week 7 | $4.41 | $7.75 | $13.62 | +0.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Silo Pharma, Inc. is a healthcare company operating as a developmental stage biopharmaceutical company. It focuses on developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases.
The company pursues traditional therapies and psychedelic treatments in formulations, with SPC-15 as its lead intranasal program targeting PTSD and stress-induced anxiety disorders. It also develops SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief, alongside preclinical programs SPC-14 for Alzheimer's disease and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). R&D collaborations include Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore.
The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Silo Pharma, Inc. (SILO) operates in the Healthcare sector as a developmental-stage biopharmaceutical company. The stock trades at $7.73 per share with a market capitalization of $8.72M and is ranked 5173. The current price and market position place it among small-cap healthcare listings.
A major floor 95.9% below — a decisive break under it would weaken the trend.
The nearest floor, 35.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 55.0% above — clearing it would confirm fresh momentum.
Key SILO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SILO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.42 | Buy | $6.40 | Buy |
| MA 10 | $6.29 | Buy | $6.31 | Buy |
| MA 20 | $6.23 | Buy | $5.88 | Buy |
| MA 50 | $3.53 | Buy | $4.25 | Buy |
| MA 100 | $1.96 | Buy | $2.83 | Buy |
| MA 200 | $1.21 | Buy | $1.85 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.00 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -129.46 | Sell |
| Williams %R (14) | -98.07 | Info |
| MACD (12,26,9) | -0.16 | Sell |
| ROC (12) | -8.65 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 1.93 | Buy |
| TRIX (15) | 3.08 | Buy |
| Awesome (5,34) | 1.42 | Buy |
| Ultimate (7,14,28) | 48.60 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 6.80 | Buy |
| ADX (14) | 42.21 | Buy |
| ATR (14) | 0.46 | Info |
The 30-day technical picture shows bullish sentiment with RSI14 at 70. The near-term averages are $6.18 for SMA50 and $6.52 for SMA200, placing price action above meaningful moving averages. The stock sits between support at $4.99 and resistance at $7.73, within a 30-day range of $5.07 to $11.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.22 | $7.73 | $10.86 | 0% | Neutral | |
| $6.54 | $9.01 | $13.43 | +17% | Neutral | |
| $5.09 | $7.46 | $11.84 | -4% | Neutral | |
| $4.65 | $7.17 | $11.96 | -7% | Neutral | |
| $5.19 | $8.40 | $14.58 | +9% | Neutral | |
| $4.91 | $8.30 | $14.91 | +7% | Neutral | |
| $6.59 | $11.63 | $21.54 | +50% | Bullish | |
| $7.24 | $13.30 | $25.32 | +72% | Bullish | |
| $6.16 | $11.76 | $22.96 | +52% | Bullish | |
| $6.42 | $12.75 | $25.46 | +65% | Bullish | |
| $8.02 | $17.81 | $39.10 | +130% | Bullish | |
| $11.74 | $26.09 | $60.02 | +238% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.22 | $7.73 | $9.01 | +0.00% |
| August 2026 | $6.09 | $7.38 | $9.31 | -4.56% |
| September 2026 | $6.32 | $7.77 | $10.02 | +5.34% |
| October 2026 | $6.15 | $7.65 | $10.03 | -1.59% |
| November 2026 | $5.99 | $7.52 | $10.01 | -1.62% |
| December 2026 | $6.35 | $8.06 | $10.86 | +7.06% |
Click any year to see its month-by-month SILO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SILO is projected to trade between $4.22 and $10.86, averaging $7.73 — a potential gain of 0% from today's $7.73. Price action looks broadly range-bound.
Silo Pharma, Inc.'s 2027 outlook centres on $9.01, within a $6.54 to $13.43 range. That is up +17% on the projected 2026 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, SILO could reach as high as $11.84, with a base case around $7.46 and support toward $5.09 — roughly -4% from $7.73. Price action looks broadly range-bound.
Expect SILO to range from $4.65 to $11.96 through 2029. The $7.17 average target implies a -7% move from current prices. That is -4% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The SILO price prediction for 2030 points to an average of $8.40 (low $5.19, high $14.58) — a potential gain of +9% on today's $7.73. Price action looks broadly range-bound.
In 2031, SILO is projected to trade between $4.91 and $14.91, averaging $8.30 — a potential gain of +7% from today's $7.73. That is -1% versus the projected 2030 average. A consolidation phase looks the most probable path here.
Silo Pharma, Inc.'s 2032 outlook centres on $11.63, within a $6.59 to $21.54 range. That is up +40% on the projected 2031 average. That marks a +50% change versus current levels. Momentum favours further upside here.
By 2033, SILO could reach as high as $25.32, with a base case around $13.30 and support toward $7.24 — roughly +72% from $7.73. Buyers look set to stay in control over this stretch.
Expect SILO to range from $6.16 to $22.96 through 2034. The $11.76 average target implies a +52% move from current prices. That is -12% versus the projected 2033 average. Momentum favours further upside here.
The SILO price prediction for 2035 points to an average of $12.75 (low $6.42, high $25.46) — a potential gain of +65% on today's $7.73. Buyers look set to stay in control over this stretch.
In 2040, SILO is projected to trade between $8.02 and $39.10, averaging $17.81 — a potential gain of +130% from today's $7.73. That is up +40% on the projected 2035 average. Momentum favours further upside here.
Silo Pharma, Inc.'s 2050 outlook centres on $26.09, within a $11.74 to $60.02 range. That is up +46% on the projected 2040 average. That marks a +238% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SILO today (≈ 129.366106 SILO) could be worth
$3,375.79
+$2,375.79 (+238%) by 2050 · US Dollar
Based on the average projected SILO price of $26.09 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SILOwould be worth at today's price.
$1,000 invested in SILO on Jul 10, 2025 (≈ 1,589.825099 SILO) would be worth
$12,289.35
+$11,289.35 (+1128.9%) today · 12.29× · US Dollar
Based on a SILO entry price of $0.629 vs. today's $7.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.18 | $1,250.81 | +25.1% |
| 1 month ago | $6.4 | $1,207.81 | +20.8% |
| 3 months ago | $0.441 | $17,528.34 | +1652.8% |
| 6 months ago | $0.395 | $19,569.62 | +1857.0% |
| 1 year ago | $0.629 | $12,289.35 | +1128.9% |
| All time (5.0y) ago | $10.65 | $725.82 | -27.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SILO forecast.
Our base-case forecast reaches $15.00 around 2040.
Implied market cap at $15.00: $16.93M
The multi-year forecast indicates upside potential with an average price of $9.27 by 2030 (min $5.73, max $16.09) and a maximum forecast of $16.09, yielding an estimated ROI of 19.9% for that year and a neutral sentiment. Beyond 2030, the outlook strengthens: 2031 avg $9.84 (ROI 27.4%), 2032 avg $13.62 (ROI 76.2%), 2033 avg $15.30 (ROI 97.9%), 2034 avg $13.58 (ROI 75.7%), and 2035 avg $14.92 (ROI 93.1%). The trajectory remains bullish into 2040 (avg $21.86, ROI 182.8%) and 2050 (avg $35.36, ROI 357.4%).
Overall, the forecast depicts growing average prices and rising ROIs over time, with sentiment turning bullish in later years, though these are estimates and not guarantees.
Tap a question to reveal the answer.
Average price: $9.27; Min: $5.73; Max: $16.09; ROI: 19.9%; Sentiment: NEUTRAL.
The forecast shows potential upside over time, with higher average prices and bullish sentiment emerging from 2031 onward. For 2030 the average is $9.27 with ROI of 19.9%, while 2026-2030 are listed as NEUTRAL. Longer-term years (2031-2050) show increasing averages and bullish sentiment, but these are estimates, not guarantees.
No. The 2050 max forecast is $81.32, with an average of $35.36 and a 2050 ROI of 357.4%.
Current price: $7.73. Market cap: $8.72M.
RSI14 is 70, indicating bullish momentum. SMA50 is $6.18 and SMA200 is $6.52. Support is at $4.99, and resistance is at $7.73, with a 30-day price range of $5.07 to $11.79 and annualized volatility of 100%.
Silo Pharma, Inc. Community Discussion
0Share your Silo Pharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.